176 related articles for article (PubMed ID: 24065233)
1. Diagnostic accuracy of Cyfra 21-1 for head and neck squamous cell carcinoma: a meta-analysis.
Wang YX; Hu D; Yan X
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2383-9. PubMed ID: 24065233
[TBL] [Abstract][Full Text] [Related]
2. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen.
Yen TC; Lin WY; Kao CH; Cheng KY; Wang SJ
Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):82-6. PubMed ID: 9563673
[TBL] [Abstract][Full Text] [Related]
3. CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma?
Rudhart SA; Schultz JD; Gehrt F; Pavel FL; Birk R; Hoch M; Stuck BA; Hoch S
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3467-3475. PubMed ID: 31482332
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of cytokeratin-19 fragment (CYFRA 21-1) for bladder cancer: a systematic review and meta-analysis.
Huang YL; Chen J; Yan W; Zang D; Qin Q; Deng AM
Tumour Biol; 2015 May; 36(5):3137-45. PubMed ID: 25854170
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
Guo XG; Long JJ
Tumour Biol; 2016 Oct; 37(10):14329-14330. PubMed ID: 27448817
[TBL] [Abstract][Full Text] [Related]
6. Study of cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma.
Céruse P; Rabilloud M; Charrié A; Dubreuil C; Disant F
Ann Otol Rhinol Laryngol; 2005 Oct; 114(10):768-76. PubMed ID: 16285267
[TBL] [Abstract][Full Text] [Related]
7. Early diagnosis of radiotherapy failure for patients with head and neck cancer: the role of biochemical markers.
Mrochem-Kwarciak J; Rutkowski T; Wygoda A; Deja R; Hajduk A; Składowski K
Tumori; 2018 Aug; 104(4):273-279. PubMed ID: 28604997
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy and prognostic applications of CYFRA 21-1 in head and neck cancer: A systematic review and meta-analysis.
Liu L; Xie W; Xue P; Wei Z; Liang X; Chen N
PLoS One; 2019; 14(5):e0216561. PubMed ID: 31071161
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of the usefulness of CYFRA 21-1 as a tumor marker in squamous cell carcinomas of the head and neck].
Sano K; Kataoka S; Katoh T; Kawauchi H; Morikawa S
Nihon Jibiinkoka Gakkai Kaiho; 1997 Jul; 100(7):790-7. PubMed ID: 9277101
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma.
Shiiya H; Ujiie H; Hida Y; Kato T; Kaga K; Wakasa S; Kikuchi E; Shinagawa N; Okada K; Ito YM; Matsuno Y
Thorac Cancer; 2021 Nov; 12(21):2933-2942. PubMed ID: 34581013
[TBL] [Abstract][Full Text] [Related]
13. The accuracy of Fiber-Optic Raman Spectroscopy in the detection and diagnosis of head and neck neoplasm
Chen W; Chen Y; Wu C; Zhang X; Huang X
PeerJ; 2023; 11():e16536. PubMed ID: 38099303
[TBL] [Abstract][Full Text] [Related]
14. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
15. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
Deng YF; Chen P; Lin YZ; Le JZ; Wu XL; Yu MQ; Zhuang PY; Gao MH
J Laryngol Otol; 2003 Mar; 117(3):190-4. PubMed ID: 12648374
[TBL] [Abstract][Full Text] [Related]
16. Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck.
Doweck I; Barak M; Greenberg E; Uri N; Kellner J; Lurie M; Gruener N
Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):177-81. PubMed ID: 7530966
[TBL] [Abstract][Full Text] [Related]
17. Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck.
Kuropkat C; Lippert BM; Werner JA
Oncology; 2002; 63(3):280-5. PubMed ID: 12381908
[TBL] [Abstract][Full Text] [Related]
18. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
19. [Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].
González Sánchez E; López-Ríos Velasco J; Calvo Boizas E; García-Talavera Fernández JR; Martín Ro-dríguez M; Muñoz Herrera A; Del Cañizo Alvarez A
Acta Otorrinolaringol Esp; 1999 Mar; 50(2):85-9. PubMed ID: 10217679
[TBL] [Abstract][Full Text] [Related]
20. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
